2-58084944-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_006296.7(VRK2):​c.250G>A​(p.Asp84Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00000568 in 1,584,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000056 ( 0 hom. )

Consequence

VRK2
NM_006296.7 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.31

Publications

1 publications found
Variant links:
Genes affected
VRK2 (HGNC:12719): (VRK serine/threonine kinase 2) This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. The encoded protein acts as an effector of signaling pathways that regulate apoptosis and tumor cell growth. Variants in this gene have been associated with schizophrenia. Alternative splicing results in multiple transcript variants that differ in their subcellular localization and biological activity. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.26712242).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VRK2NM_006296.7 linkc.250G>A p.Asp84Asn missense_variant Exon 4 of 13 ENST00000340157.9 NP_006287.2 Q86Y07-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VRK2ENST00000340157.9 linkc.250G>A p.Asp84Asn missense_variant Exon 4 of 13 1 NM_006296.7 ENSP00000342381.4 Q86Y07-1

Frequencies

GnomAD3 genomes
AF:
0.00000659
AC:
1
AN:
151650
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
229838
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000558
AC:
8
AN:
1433014
Hom.:
0
Cov.:
29
AF XY:
0.00000562
AC XY:
4
AN XY:
711880
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32260
American (AMR)
AF:
0.00
AC:
0
AN:
41766
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25370
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38648
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80500
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51948
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5674
European-Non Finnish (NFE)
AF:
0.00000729
AC:
8
AN:
1097970
Other (OTH)
AF:
0.00
AC:
0
AN:
58878
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000659
AC:
1
AN:
151650
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74068
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41344
American (AMR)
AF:
0.00
AC:
0
AN:
15192
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10566
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000148
AC:
1
AN:
67758
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000283
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 15, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.250G>A (p.D84N) alteration is located in exon 4 (coding exon 3) of the VRK2 gene. This alteration results from a G to A substitution at nucleotide position 250, causing the aspartic acid (D) at amino acid position 84 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.43
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
.;T;.;T;.
Eigen
Benign
0.18
Eigen_PC
Uncertain
0.34
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.86
D;.;D;D;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.27
T;T;T;T;T
MetaSVM
Benign
-0.69
T
MutationAssessor
Benign
1.3
L;L;L;L;.
PhyloP100
5.3
PrimateAI
Benign
0.41
T
PROVEAN
Uncertain
-2.8
.;D;D;D;D
REVEL
Benign
0.15
Sift
Benign
0.041
.;D;T;D;D
Sift4G
Benign
0.10
.;T;T;T;T
Polyphen
0.66
P;B;B;B;.
Vest4
0.28, 0.28, 0.27, 0.34
MutPred
0.49
Gain of MoRF binding (P = 0.0566);Gain of MoRF binding (P = 0.0566);Gain of MoRF binding (P = 0.0566);Gain of MoRF binding (P = 0.0566);.;
MVP
0.69
MPC
0.015
ClinPred
0.93
D
GERP RS
5.9
Varity_R
0.17
gMVP
0.51
Mutation Taster
=66/34
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1394584415; hg19: chr2-58312079; API